Growth factors and DLI in adult haploidentical transplant: A three-step pilot study towards patient and disease status adjusted management

Blood Cells, Molecules, and Diseases

Volumn 33, Issue 3, 2004, Pages 256-260

  Lewalle, P ^a   Delforge, A ^a   Aoun, M ^a   Crombez, P ^a   De Wilde, V ^a   Theunissen, K ^b   Lagneaux, L ^a   Nowak, B ^a   Misplon, V ^a   Bron, D ^a   Martiat, P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Donor lymphocyte infusion; Graft versus leukemia; Growth factors; Haploidentical

Indexed keywords

ACICLOVIR; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; CYTOMEGALOVIRUS ANTIBODY; DEFIBROTIDE; FLUDARABINE; FRESENIUS; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMATINIB; ITRACONAZOLE; MELPHALAN; PENTAMIDINE; PREDNISONE; PYRIMETHAMINE; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOIMMUNITY; ASPERGILLOSIS; ASPERGILLUS; CAUSE OF DEATH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DONOR LYMPHOCYTE INFUSION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL STEM CELL TRANSPLANTATION; HAPLOIDY; HUMAN; IMMUNITY; INFECTION; INFUSION; LUNG INJURY; LYMPHOCYTE; MALE; MORTALITY; NATURAL KILLER CELL; PHASE 1 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RECURRENCE RISK; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TOXICITY; TOXOPLASMOSIS; VEIN OCCLUSION; VIRUS INFECTION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HAPLOTYPES; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSPLANTATION CONDITIONING;

ASPERGILLUS; CUCUMBER MOSAIC VIRUS;

EID: 7444259102     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2004.08.012     Document Type: Conference Paper

References (21)

1. F. Aversa, A. Tabilio, and A. Terenzi Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
2. F. Aversa, A. Tabilio, and A. Velardi Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical "three loci" incompatible donors N. Engl. J. Med. 339 1998 1186 1193
3. H.J. Kolb, W. Guenther, B. Gyurkocza, and F. Hoetzl Tolerance and chimerism Transplantation 75 9 Suppl. 2003 26S 31S
4. P. Lewalle, A. Triffet, and A. Delforge Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study Bone Marrow Transplant. 31 2003 39 44
5. F. Aversa, A. Terenzi, and R. Felicini Haploidentical stem cell transplantation for acute leukemia Int. J. Hematol. 76 Suppl. 1 2002 165 168
6. F. Aversa, A. Velardi, and A. Tabilio Haploidentical stem cell transplantation in leukemia Blood Rev. 15 2001 111 119
7. H.J. Kolb, C. Schmid, and A.J. Barrett Graft-versus-leukemia reactions in allogeneic chimeras Blood 103 2004 767 776
8. S. Kato, H. Yabe, M. Yasui, et al., Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haploidentical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood.
9. M.W. Lowdell, R. Craston, and N. Ray The effect of T cell depletion on immune reconstitution after chemotherapy and allogeneic bone marrow transplantation as treatment for leukemia Bone Marrow Transplant. 21 1998 679 686
10. L. Ruggeri, M. Capanni, and M. Casucci Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 94 1999 333 339
11. L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
12. J.M. Goldman, R.P. Gale, and M.M. Horowitz Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion Ann. Intern. Med. 108 1988 806 814
13. I. Volpi, K. Perruccio, and A. Tosti Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants Blood 97 2001 2514 2521
14. Bone Marrow Transplant. 26 12 2000 1281 1290
15. M. Arpinati, C.L. Green, and S. Heimfeld Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood 95 2000 2484 2490
16. L.A. Bober, M.J. Grace, and C. Pugliese-Sivo The effect of GM-CSF and G-CSF on human neutrophil function Immunopharmacology 29 1995 111 119
17. T. Hartung Anti-inflammatory effects of granulocyte colony-stimulating factor Curr. Opin. Hematol. 5 1998 221 225
18. A. O'Garra Cytokines induce the development of functionally heterogeneous T helper cell subsets Immunity 8 1998 275 283
19. E.M. Sloand, S. Kim, and J.P. Maciejewski Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo Blood 95 2000 2269 2274
20. E.J. Gerritsen, E.D. Stam, and J. Hermans Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children Bone Marrow Transplant. 18 1996 377 382
21. K.S. Peggs, S. Verfuerth, and A. Pizzey Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines Lancet 362 2003 1375 1377